PMID- 34621771 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20211009 IS - 2296-861X (Print) IS - 2296-861X (Electronic) IS - 2296-861X (Linking) VI - 8 DP - 2021 TI - The Effect of Oral Nutritional Formula With Three Different Proteins on Type 2 Diabetes Mellitus in vivo. PG - 680700 LID - 10.3389/fnut.2021.680700 [doi] LID - 680700 AB - Oral nutritional (ON) products are an effective way to treat patients with type 2 diabetes mellitus (T2DM) whose gastrointestinal functions are normal. The influence of ON formula prepared with three different proteins on T2DM was studied. The hyperglycaemic mouse model using a high-fat diet (HFD) combined with an intraperitoneal injection of streptozotocin (STZ) was used to simulate T2DM. The study was done for 15 weeks using seven groups of mice: control group (CG, normal mice, and normal food), non-treated group (BG, diabetic mice, and normal food), positive control group (PG, diabetic mice, and HFD), soybean protein group (SPG, diabetic mice, and HFD), silkworm pupa protein group (SPPG, diabetic mice, and HFD), whey protein group (LPG, diabetic mice, and HFD), and whey protein combined with silkworm pupa protein group (LCSSPG, diabetic mice, and HFD). The plasma levels of total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) were analyzed on weeks 2, 10, 12, 14, and 15. The concentration of total protein (TP) and albumin (ALB) of the plasma was increased in SPG, SPPG, and PG comparing with BG (p < 0.05). The TC, TG, and LDL-C levels were decreased, and HDL-C level was increased in SPG, PG, SPPG, PG comparing with BG (p < 0.05). Blood glucose (BLG) levels were decreased 47, 34, 24, and 21% in SPG, LCSSPG, SPPG, and PG, respectively. While BLG was not significantly changed (p >/= 0.05) in LG after 5 weeks of treatment. Overall, the data suggested that consumption of SP, SPP, LCSSPG Oral-formula may be beneficial for the treatment of T2DM. CI - Copyright (c) 2021 Jia, Leng, Cruz, Bao, Bao, Wu, Wang and Ma. FAU - Jia, Ye AU - Jia Y AD - Shanghai Ocean University, College of Food Science and Technology, Shanghai, China. FAU - Leng, Yue AU - Leng Y AD - Shanghai Ocean University, College of Food Science and Technology, Shanghai, China. FAU - Cruz, Aliannys Lazara Puente AU - Cruz ALP AD - Grupo Empresarial de la Industria Alimentaria, Havana, Cuba. FAU - Bao, Chun Ling AU - Bao CL AD - East Hospital of Shanghai Sixth People's Hospital, Shanghai, China. FAU - Bao, Bin AU - Bao B AD - Shanghai Ocean University, College of Food Science and Technology, Shanghai, China. FAU - Wu, Wenhui AU - Wu W AD - Shanghai Ocean University, College of Food Science and Technology, Shanghai, China. FAU - Wang, Peipei AU - Wang P AD - Shanghai Ocean University, College of Food Science and Technology, Shanghai, China. AD - Tarim University, Xinjiang Production and Construction Corps Key Laboratory of Protection and Utilization of Biological Resourses in Tarim Basin, XinJiang, China. FAU - Ma, Ming AU - Ma M AD - Shanghai Ocean University, College of Food Science and Technology, Shanghai, China. LA - eng PT - Journal Article DEP - 20210921 PL - Switzerland TA - Front Nutr JT - Frontiers in nutrition JID - 101642264 PMC - PMC8490655 OTO - NOTNLM OT - oral nutritional formula OT - silkworm pupa protein OT - soybean protein OT - type 2 diabetes mellitus OT - whey protein COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2021/10/09 06:00 MHDA- 2021/10/09 06:01 PMCR- 2021/01/01 CRDT- 2021/10/08 07:12 PHST- 2021/03/15 00:00 [received] PHST- 2021/08/05 00:00 [accepted] PHST- 2021/10/08 07:12 [entrez] PHST- 2021/10/09 06:00 [pubmed] PHST- 2021/10/09 06:01 [medline] PHST- 2021/01/01 00:00 [pmc-release] AID - 10.3389/fnut.2021.680700 [doi] PST - epublish SO - Front Nutr. 2021 Sep 21;8:680700. doi: 10.3389/fnut.2021.680700. eCollection 2021.